Comparing the Accuracy of FTIR Imaging and QCL Technology for the Differentiation Between Chromophobe Renal Cell Carcinoma and Oncocytoma

Abstract

Renal Cell Carcinoma (RCC) is the deadliest urological cancer. Chromophobe RCC makes up approximately 5% of all renal tumors. This leads to improper filtration of the blood which causes symptoms such as blood in the urine, back or side pain, loss of appetite, weight loss, fatigue, and fever. Renal Oncocytoma is a common benign renal neoplasm but shares many characteristics with Chromophobe RCC making them difficult to distinguish from one another. Use of Fourier Transform Infrared (FTIR) Spectroscopy and Quantum Cascade Laser (QCL) technology have been shown to be accurate at identifying a neoplasm and determining the malignancy of it.